Vir Biotechnology Prices $150 Million Stock Offering at $10 Per Share
Vir Biotechnology agreed to sell 15 million common shares at $10 each for $150 million in gross proceeds. Underwriters have a 30-day option to purchase up to 2.25 million additional shares.
Vir Biotechnology entered into an underwriting agreement with Leerink Partners, Morgan Stanley and Evercore for an offering of 15 million common shares at $10 per share, representing $150 million in gross proceeds. The underwriters have a 30-day option to purchase up to 2.25 million additional shar…